NCT07459582 Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glycogen Storage Disease
| NCT ID | NCT07459582 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Connecticut Children's Medical Center |
| Condition | Glycogen Storage Disease Type IA |
| Study Type | OBSERVATIONAL |
| Enrollment | 10 participants |
| Start Date | 2026-08 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10 participants in total. It began in 2026-08 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to determine if the Lactate Plus meter is accurate compared to lab lactate levels, and to determine if the Accu chek guide glucometer is accurate compared to lab serum glucose levels in patients with Glycogen Storage Disease Types Ia, Ib and XI. To determine this, patient's will have a one-time planned admission to Connecticut Children's for approximately 8 hours and receive hourly blood draws as well as finger-sticks.
Eligibility Criteria
Inclusion Criteria: 1. Patients with diagnosed/confirmed (by liver biopsy or genetic testing) Glycogen Storage Disease Type Ia/Ib (ICD 10 code: E74.01) or XI (74.09). 2. For pediatric participants: Ability of child's parent/legal guardian to understand and the willingness to sign a written informed consent document 3. For adolescents: assent to participate 4. For adults: Ability to understand and the willingness to sign a written informed consent Exclusion Criteria: 1. Patients with Glycogen storage disease unspecified 2. Patients not meeting inclusion criteria 3. Patients unable to provide consent 4. Patients who decline to be in the study
Contact & Investigator
Malaya Mount, MS, RD, CDN
PRINCIPAL INVESTIGATOR
Connecticut Children's
Frequently Asked Questions
Who can join the NCT07459582 clinical trial?
This trial is open to participants of all sexes, up to 60 Years, studying Glycogen Storage Disease Type IA. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07459582 currently recruiting?
Yes, NCT07459582 is actively recruiting participants. Contact the research team at mmount@connecticutchildrens.org for enrollment information.
Where is the NCT07459582 trial being conducted?
This trial is being conducted at Hartford, United States.
Who is sponsoring the NCT07459582 clinical trial?
NCT07459582 is sponsored by Connecticut Children's Medical Center. The principal investigator is Malaya Mount, MS, RD, CDN at Connecticut Children's. The trial plans to enroll 10 participants.